Calreticulin transacylase: Genesis, mechanism of action and biological applications

Biochimie

Volumn 92, Issue 9, 2010, Pages 1173-1179

  Kumari, Ranju ^a,g   Bansal, Seema ^a,h   Gupta, Garima ^a   Arora, Shvetambri ^a   Kumar, Ajit ^a   Goel, Sanjay ^a   Singh, Prabhjot ^a   Ponnan, Prija ^a,b   Priya, Nivedita ^a   Tyagi, Tapesh K ^a   Baghel, Anil S ^a   Manral, Sushma ^a   Tandon, Rashmi ^a   Joshi, Rini ^a   Rohil, Vishwajeet ^a   Gaspari, Marco ^c   Kohli, Ekta ^a,i   Tyagi, Yogesh K ^a,j   Dwarakanath, Bilikere S ^d   Saluja, Daman ^e   Chatterji, Suvro ^f   Sharma, Sunil K ^b   Prasad, Ashok K ^b   Rastogi, Ramesh C ^b   Raj, Hanumantharao G ^a   Parmar, Virinder S ^b   more..

^a UNIVERSITY OF DELHI   (India)

^b UNIVERSITY OF DELHI   (India)

^c Dipartimento di Medicina Sperimentale e Clinica   (Italy)

^d INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^e UNIVERSITY OF DELHI   (India)

^f AU KBC Research Centre   (India)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

^j GURU GOBIND SINGH INDRAPRASTHA UNIVERSITY   (India)

more..

Author keywords

Autoacylation; Calreticulin; Calreticulin transacylase; Polyphenolic acetate; Protein acetylation

Indexed keywords

ACYLTRANSFERASE; CALCIUM ION; CALRETICULIN; CALRETICULIN TRANSACETYLASE; CYTOCHROME P450; GLUTATHIONE TRANSFERASE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; UNCLASSIFIED DRUG;

ACETYLATION; ANGIOGENESIS; CATALYSIS; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; GENOTOXICITY; MICROSOME; MOLECULAR WEIGHT; NONHUMAN; RAT; REVIEW; VASODILATATION;

ACETYLATION; ACETYLTRANSFERASES; ANIMALS; CALRETICULIN; HAEMONCHUS; HUMANS; MODELS, BIOLOGICAL;

HAEMONCHUS CONTORTUS; MAMMALIA;

EID: 77955841800     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.01.016     Document Type: Review

References (37)

1. Raj H.G., Parmar V.S., Jain S.C., et al. Mechanism of biochemical action of substituted 4-methylbenzopyran-2-one. Part II: mechanism-based inhibition of rat liver microsome-mediated aflatoxin B1-DNA binding by the candidate antimutagen 7,8-diacetoxy-4-methylcoumarin. Bioorg. Med. Chem. 1998, 6:1895-1904.
2. Raj H.G., Kohli E., Rohil V., et al. Acetoxy of 4-methylcoumarins confer differential protection from aflatoxinB1-induced micronuclei and apoptosis in lung and bone marrow cells. Mut. Res. 2001, 494:31-40.
3. Raj H.G., Kohli E., Goswami R., et al. Mechanism of biochemical action of substituted benzopyran-2-ones. Part 8: acetoxycoumarin: protein transacetylase-specificity for aromatic nuclear acetoxy groups in proximity to the oxygen heteroatom. Bioorg. Med. Chem. 2001, 9:1085-1089.
4. Singh I., Kohli E., Raj H.G., et al. Mechanism of biochemical action of substituted 4-methylbenzopyran-2-ones. Part 9: comparison of acetoxy 4-methylcoumarins and other polyphenolic acetates reveal the specificity to acetoxy drug: protein transacetylase for pyran carbonyl group in proximity to the oxygen heteroatom. Bioorg. Med. Chem. 2002, 10:4103-4111.
5. Kumar A., Singh B.K., Tyagi R., Jain S.K., et al. Mechanism of biochemical action of substituted 4-methylcoumarins. Part 11: comparison of the specificities of acetoxy derivatives of 4-methylcoumarin and 4-phenylcoumarin to acetoxycoumarins: protein transacetylase. Bioorg. Med. Chem. 2005, 13:4300-4305.
6. Kumar A., Singh B.K., Sharma N.K., et al. Specificities of acetoxy derivatives of coumarins, biscoumarins, chromones, flavones, isoflavones and xanthones for acetoxy drug:protein transacetylase. Eur J. Med. Chem. 2006, 42:447-455.
7. Habig W.H., Pabst M.J., Jacoby W.B. Glutathione S-transferases: the first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249:7130-7139.
8. Raj H.G., Parmar V.S., Jain S.C., et al. Mechanism of biochemical action of substituted 4-methylbenzopyran-2-one. Part 7: assay and characterization of 7,8-diacetoxy-4-methylcoumarin: protein transacetylase from rat liver microsomes based on the irreversible inhibition of cytosolic glutathione S-transacetylase. Bioorg. Med. Chem. 2000, 8:1707-1712.
9. Raj H.G., Parmar V.S., Jain S.C., et al. Mechanism of biochemical action of substituted 4-methylbenzopyran-2-one. Part 4: hyperbolic activation of rat liver microsomal NADPH-cytochrome c reductase by the novel acetylator 7,8-diacetoxy-4-methylcoumarin. Bioorg. Med. Chem. 1999, 7:369-373.
10. A. Cornish-Bowden (Ed.), Fundamentals of Enzyme-Kinetics, London: Portland Press Ltd; 1979, pp. 115-116.
11. Raj H.G., Kumari R., Seema, Gupta G., et al. Novel function of calreticulin: characterization of calreticulin as a transacetylase-mediating protein acetylator independent of acetyl CoA using polyphenolic acetates. Pure Appl. Chem. 2006, 78:985-992.
12. Kohli E., Gaspari M., Raj H.G., et al. Establishment of the enzymatic protein acetylation independent of acetyl CoA: recombinant glutathione S-transferase 3-3 is acetylated by a novel membrane-bound transacetylase using 7,8-diacetoxy 4-methyl coumarin as the acetyl donor. FEBS Lett. 2002, 530:139-142.
13. Kohli E., Gaspari M., Raj H.G., et al. Acetoxy drug: protein transacetylase of buffalo liver-characterization and mass spectrometry of the acetylated protein product. Biochem. Biophys. Acta 2004, 1698:55-66.
14. Seema, Kumari R., Gupta G., et al. Characterization of protein transacetylase from human placenta as a signaling molecule calreticulin using polyphenolic peracetates as the acetyl group donors. Cell Biochem. Biophys. 2007, 47:53-64.
15. Bansal S., Gaspari M., Raj H.G., et al. Calreticulin transacetylase mediates the acetylation of nitric oxide synthase by polyphenolic acetate. Appl. Biochem. Biotechnol. 2008, 144:37-45.
16. Nadler S.G., Strobel H.W. Role of electrostatic interactions in the reaction of NADPH-cytochrome P-450 reductase with cytochrome P-450. Arch. Biochem. Biophys. 1988, 261:418-429.
17. Li Z., Komatsu S. Molecular cloning and characterization of calreticulin, a calcium-binding protein involved in the regeneration of rice-cultured suspension cells. Eur. J. Biochem. 2000, 267:737-745.
18. Bansal S., Ponnan P., Raj H.G., et al. Autoacetylation of purified calreticulin transacetylase utilizing acetoxycoumarin as the acetyl group donor. Appl. Biochem. Biotechnol. 2009, 157:285-298.
19. Choi C.H., Hiromura M., Usheva A. Transcription factor IIB acetylates itself to regulate transcription. Nature 2003, 424:965-969.
20. Thompson P.R., Wang D., Wang L., et al. Regulation of the p300 HAT domain via a novel activation loop. Nat. Struct. Mol. Biol. 2004, 11:308-315.
21. P. Singh, P. Ponnan, S. Krishnan, et al., Protein acyltransferase function of purified calreticulin. Part 1: characterization of propionylation of protein utilizing propoxycoumarin as the propionyl group donor, J. Biol. (2010). doi:10.1093/jb/mvq002.
22. Chen Y., Sprung R., Tang Y., et al. Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol. Cell. Proteomics 2007, 6:812-819.
23. Michalak M., Corbett E.F., Mesaeli N., Nakamura K., Opas M. Calreticulin: one protein, one gene, many functions. Biochem. J. 1999, 344:281-292.
24. Michalak M., Groenendyk J., Szabo E., Gold L.I., Opas M. Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum. Biochem. J. 2009, 417:651-656.
25. Suchitra S., Joshi P. Characterization of Haemonchus contortus calreticulin suggests its role in feeding and immune evasion by the parasite. Biochim. Biophys. Acta 2005, 1722:293-303.
26. Shaw B.F., Schneider G.F., Bilgicxer B., et al. Lysine acetylation can generate highly charged enzymes with increased resistance toward irreversible inactivation. Protein Sci. 2008, 17:1446-1455.
27. Weber H.K., Zuegg J., Faber K., Pleiss J. Molecular reasons for lipase-sensitivity against acetaldehyde. J. Mol. Catal. B: Enzymol. 1997, 3:131-138.
28. Raj H.G., Malik S., Parmar V.S., et al. Chemoprevention of benzene induced bone marrow and pulmonary genotoxicity. Terat. Carcinogen. Mutagen 2001, 21:181-187.
29. 1-induced genotoxicity by quercetin and quercetin pentaacetate. Bioorg. Med. Chem. Lett. 2002, 12:2579-2582.
30. 1 in bone marrow and lung cells. J. Pharm. Pharmacol. 2007, 1:81-86.
31. Khurana P., Kumari R., Vohra P., et al. Acetoxy drug: protein transacetyalse catalyzed activation of human platelet nitric oxide synthase by polyphenolic peracetates. Bioorg. Med. Chem. 2006, 14:575-583.
32. Charles H., Hennekens M.D., Mark L., Dyken M.D., Valentin Fuster M.D. Aspirin as a therapeutic agent in cardiovascular disease. Circulation 1997, 96:2751-2753.
33. H.G. Raj, A. Kumar, R. Kumari, et al., Prospects for the development of polyphenolic acetate as the potential drug candidate: A review. Compendium of bioactive natural products, Vol. 7: Structural modifications & drug development bioactive natural products, Studium Press LLC, USA, in press.
34. Forstermann U., Closs E.I., Pollock J.S., et al. Nitric oxide synthase isozymes: characterization, purification, molecular cloning, and functions. Hypertension 1994, 23:1121-1131.
35. Arora S., Tyagi Y.K., Kumar A., et al. The role of calreticulin transacetylase in the activation of human platelet nitrite reductase by polyphenolic acetates. Biol. Pharm. Bull. 2009, 32:161-165.
36. Lundberg J.O., Weitzberg E. NO generation from nitrite and its role in vascular control. Arterioscler. Thromb. Vasc. Biol. 2005, 25:915-922.
37. Pyriochoua A., Vassilakopoulosb T., Zhoub Z., Papapetropoulosa A. cGMP-dependent and independent angiogenesis-related properties of nitric oxide. Life Sci. 2007, 81:1549-1554.